I have not done a deep dive into the infection-fighting drugs with regard to their impact on memory and brain function - so I can’t comment on that.
We are still in the very earliest days with regard to possible uses of these antiviral type drugs in longevity protocols. I’m open to trying these, given the good safety data I could find (and taking Dr. Fraser’s perspective that you want to be careful with drug/drug interactions, so may want to pause rapamycin while initiating any trials). But so far I’ve seen nobody even trying these drugs in longevity applications yet. I think it would be interesting to do a battery of pre-testing of cognitive function, such as done via the NeuroAge app: Predicting Alzheimers & Dementia (and minimizing risk) - #313 by RapAdmin , and then retesting after a week or a month of using Maraviroc.
I’ve seen no studies that link drugs like Maraviroc to increased lifespan, so I think the data so far is limited to specific areas, though broadly of course inflammation is an issue in aging, so there could be some systemic benefits.
Right on, thanks for the reply. Glad to hear all that. Had no idea.
Hopefully you can trial Maraviroc one day and share your review on it.
You bring up a good point about it being limited to specific areas, and it appears to be only available in a few continents.
Might be a while before seeing any results for increased lifespan from the data.
Though would be cool to have people who use (or can get) these medications and do various testing such as the cognitive tests, or other types of testing such as rate of aging, blood testing etc - to see if there is anything good or bad with the testing.